BioCentury
ARTICLE | Company News

Itamar Medical Ltd., Roche deal

January 9, 2012 8:00 AM UTC

Itamar received a $250,000 milestone payment from Roche under a 2010 deal to develop an EndoPAT device for Roche to assess endothelial dysfunction of cardiovascular compounds in animal models. Itamar said the milestone was triggered by the partners' decision to continue further development of the device. Details were not disclosed (see BioCentury, Jan. 3, 2011). ...